Navigation Links
Stille and Enova Form Strategic Partnership to Introduce World's Brightest LED Cordless Surgical Headlights Into Europe and Japan
Date:9/24/2007

ST. PAUL, Minn., Sept. 24 /PRNewswire/ -- Enova Medical Technologies and Stille AB (listed at First North Sweden) are pleased to announce that they have entered into a strategic marketing and distribution partnership. Beginning in the 4th quarter of 2007, Stille will market Enova's breakthrough LED cordless headlights to the surgical market with exclusive rights in Scandinavia, Great Britain and Italy and, on a non-exclusive basis, throughout the rest of Europe and Japan. The products will be added to Stille's existing medical product line and marketed under the Stille brand.

"Enova has been proud to be on the cutting edge of surgical lighting technology by offering the world's brightest cordless surgical headlights in the United States. Now, through our partnership with Stille, we are excited to begin offering these devices to physicians throughout Europe and Japan," said Fariborz Boor Boor, CEO of Enova. "As we expand our international sales, we are targeting only 'the best of class' distributors. We are convinced that Stille, with its well known brand and established distribution network, is the right partner for us."

A leader in cordless LED surgical headlight innovation, Enova has evolved LED technologies to achieve cordless lighting output that exceeds 100,000 lux. Enova's LED headlights replace traditional tethered lighting devices, which require expensive and cumbersome Halogen or Xenon light sources. Enova's LED technology provides the brightest and whitest cordless lighting available on today's market, lasts over 50,000 hours, and offers surgeons complete mobility and freedom during operations.

"This agreement is in line with Stille's strategy to expand our product offering to surgeons with only the highest quality innovative products," says Anders Weilandt, CEO of Stille. "Enova's LED headlight technology complements our 166-year history of surgical excellence and offers tremendous synergies with our sales, marketing and distribut
'/>"/>

SOURCE Enova Medical Technologies
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Wet Distillers Grains Could Play a Role in Cattle Diets
2. Canadians Urged to Renovate Houses to Check Radon Gas Radiation
3. Pharma cos must forge Strategic alliances
4. Zydus Cadila and Kopran in strategic alliance
5. A strategic study: Soy diet makes heart disease to worsen in male mice
6. Researchers Make a Major Strategic Breakthrough in Controlling the AIDS Virus
7. NHS Makes A Strategic Move For The Dentists From Leaving Its Services
8. Thailand Approves Strategic Plan To Reduce HIV Prevalence Among Youth
9. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
10. Partnership Between Diabetes India And Elsevier Announced
11. Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Just about any bodyweight training program includes a variety of ... Dallas, GA that uses a variety of bodyweight conditioning circuits ... used enough. , “The medicine ball pushup is ... By keeping your hands on a medicine ball, the core ... much harder than a standard pushup. This unique bodyweight chest ...
(Date:5/24/2013)... 24, 2013 For the second consecutive ... Fresh Express Café to treat Tabitha Meals on Wheels ... their door. More than 400 meal recipients recently enjoyed ... restaurants, along with the rest of a well-balanced, nutritious ... to partner with the Tabitha Meals on Wheels team,” ...
(Date:5/24/2013)... have today released updated guidelines on Hormone Replacement Therapy ... the benefits and the risks. The new guidelines appear ... published by SAGE. , Over the last 11 ... of youth" to being considered extremely risky and only ... of the Women,s Health Initiative (WHI) trial in 2002, ...
(Date:5/24/2013)... Bridal Buy , a leading wedding ... 2013 bridesmaid dresses are available in its wedding ... featured as fine fabrics, elegant beading, and exquisite embroidery. ... and an eye for detailed designs. However, our lace ... life from patterns and the hands of dressmakers,” said, ...
(Date:5/24/2013)... Psoriasis treatment cream has been released online for ... registered company is now offering its natural solution to ... infected skin. , Dermasis has launched its new psoriasis ... cream is designed to offer immediate relief to those ... red skin often caused by psoriasis outbreaks. This new ...
Breaking Medicine News(10 mins):Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2
... , SAN DIEGO, July 21 ... Anakam.TFA(R) Two-Factor Authentication as the enterprise authentication tool for ... to help the VA provide more veteran-centric benefit and ... cost-effective citizen-facing two-factor authentication solution delivered through multiple channels ...
... , , , ... historic show of unity, advocates for all the health Millennium Development Goals ... commitments to health by chronically underfunding programs for AIDS, TB, maternal and ... globe. , , The coalition of ...
... , BALTIMORE, July 21 Stayhealthy, Inc., a leader ... take control of their health, and Innovative Wellness Solutions a leader ... have reached an agreement to bring a powerful new solution to ... , , Wellness in the workplace ...
... SHENZHEN, China, July 21 /PRNewswire-Asia-FirstCall/ -- ... the,Company has changed its name to "BioPharm Asia, Inc." ... place in the next three to four weeks,in accordance ... name change to BioPharm Asia, Inc. will be reflected ...
... , , MONROVIA, Calif., July ... developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that ... Division of Bioresearch Monitoring that the restrictions of the "integrity hold" put ... The removal of the integrity hold enables the FDA to resume ...
... , , NEW YORK, July 21 ... cleanse Food & Wine Magazine recently dubbed ... State by announcing today that it will offer free delivery to anywhere in ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090721/LA49137 ) , , ...
Cached Medicine News:Health News:Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 2Health News:Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 4Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 5Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 6Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 7Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 8Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:Domain Registration Corp. Announces Name Change to 'BioPharm Asia, Inc.' 2Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 2Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 3Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 4Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 5Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 2Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 3
(Date:5/24/2013)... 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the ... announced today that Dr. Robert Grieve , ... Jason Napolitano , executive vice president and chief financial ... which is being held May 30, 2013 in ... The Company,s presentation is scheduled to begin ...
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... CHESTERBROOK, Pa. , May 24, 2013  Auxilium ... that executive management will participate in the Deutsche Bank ... the Westin Boston Waterfront Hotel.  Mr. Adrian ... scheduled to present an overview of the Company and ... May 29, 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... Campath May Lead to Overall Survival in Patients with Poor ... FRANCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals Inc. today announced ... showed activity in high-risk chronic lymphocytic leukemia (CLL) patients who ... 50th Annual Meeting of the American Society of Hematology in ...
... 8 Millennium: The Takeda Oncology Company today ... of patients from the large, international Phase III ... with previously untreated multiple myeloma given VELCADE, melphalan ... efficacy in all patient sub-groups, including those with ...
Cached Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
5mSports™ is the handheld version of 5 Minute Sports Medicine Consult, your favorite reference for on-field and off-field treatment of sports related problems....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... the essential information that every intern ... wards, including the neurologic history and ... neuroimaging techniques and diagnostic tools, and ... dizziness, and ataxia, acute vision loss, ...
... all-original guide prepared specifically for ... from "PocketMedicine/Internal Medicine", it will ... those training in the field, ... are frequently the first to ...
Medicine Products: